As a result of the COVID-19 pandemic, pharmaceutical companies are changing how they engage with healthcare providers, which in turn is helping providers better serve patients, according to findings of a global Accenture survey of 720 general practitioners, oncologists, cardiologists and immunologists. For example, most providers said pharma companies are increasingly providing education on how to better treat patients remotely and help them manage their conditions in light of COVID-19.
|